Impact of ANXA5 polymorphisms on glioma risk and patient prognosis
Glioma, the most common primary malignant brain tumor, is highly malignant with a poor prognosis. We aimed to clarify the relevance of ANXA5 polymorphisms to glioma risk and prognosis among the Chinese Han population.
Six single-nucleotide polymorphisms (SNPs) of ANXA5 were genotyped by Agena MassARRAY in 593 glioma patients and 589 healthy controls. Logistic regression model was used to calculate odds ratios (OR) and 95% confidence intervals (CI). The association between polymorphisms and survival were evaluated using the log-rank test, Kaplan–Meier analysis and Cox regression model.
We found that rs117677079 polymorphism was strongly associated with an increased risk of glioma (OR 1.64, p = 0.003) and a worse prognosis for glioma, especially in high-grade glioma (HR 1.76, p = 0.005). Whereas, rs145619195 CT genotype might weaken the susceptibility (OR 0.63, p = 0.024) and prognosis (HR 0.20, p = 0.025) of glioma. Haplotype analysis showed that haplotype ″GACCG″ in the block (rs41278075, rs2306420, rs117677079, rs2306415 and rs1131239) significantly decreased the susceptibility of glioma (OR 0.61, p = 0.003). Furthermore, we also found that age, extent of resection and chemotherapy were key prognostic factors in glioma patients.
This study firstly provided evidence for the impact of ANXA5 polymorphism on the susceptibility and prognosis of glioma, suggesting ANXA5 variants might have potential roles in the etiology of glioma.
KeywordsGlioma ANXA5 variants Susceptibility Prognosis
We are grateful to the individuals who participated in this study. We also thank the clinicians and hospital staff who contributed to the sample and data collection for this study.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- 1.Amirian ES, Armstrong GN, Zhou R et al (2016) The Glioma International Case-Control Study: a report from the genetic epidemiology of Glioma International Consortium. Am J Epidemiol 183(2):85–91Google Scholar
- 6.Jin T, Wang Y, Li G et al (2015) Analysis of difference of association between polymorphisms in the XRCC5, RPA3 and RTEL1 genes and glioma, astrocytoma and glioblastoma. Am J Cancer Res 5(7):2294–2300Google Scholar
- 8.Li G, Jin T, Liang H et al (2013) RTEL1 tagging SNPs and haplotypes were associated with glioma development. Diagn Pathol 8(1):83Google Scholar
- 21.Ding XM, Li JX, Wang K et al (2017) Effects of silencing annexin A5 on proliferation and invasion of human cholangiocarcinoma cell line. Eur Rev Med Pharmacol Sci 21(7):1477–1488Google Scholar
- 23.Nasef A, Ibrahim M, Riad N, Mousa S (2014) Plasma annexin A5, anti-annexin A5 antibodies and annexin A5 polymorphism in Egyptian female patients with systemic lupus erythematosus and antiphospholipid syndrome. Clin Lab 60(1):133–137Google Scholar